Chemed (CHE) revenue breakdown
By segment, VITAS is the largest at 64% of fiscal 2025 revenue; Roto-Rooter grew fastest, 12% a year over 6 years.
By product, Routine Home Care is the largest at 85% of fiscal 2024 revenue, growing 4% a year over 5 years.
Revenue by segment
Fiscal years, as Chemed reports them in its 10-K filings; fiscal 2025 total $2.5B.
| Segments | 2016 | 2017 | 2018 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| VITAS | $1.1B | $1.1B | $1.2B | $1.2B | $1.3B | $1.5B | $1.6B | 64% |
| Roto-Rooter | $454M | $518M | $585M | $933M | $949M | $900M | $900M | 36% |
Revenue by product
Fiscal years, as Chemed reports them in its 10-K filings; fiscal 2024 total $1.6B.
| Products | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Share |
|---|---|---|---|---|---|---|---|
| Routine Home Care | $1.1B | $1.1B | $1.1B | $1.0B | $1.1B | $1.3B | 85% |
| Inpatient Care | $100M | $115M | $113M | $102M | $112M | $121M | 8% |
| Continuous Care | $133M | $136M | $94M | $77M | $86M | $100M | 6% |
| All Other Revenue- Self-pay, Respite Care, Etc. | $10M | $11M | $12M | $12M | $14M | $19M | 1% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CHE.
Open CHE in InvestinglyQuestions
Where does Chemed make its money?
In fiscal 2025, by segment: VITAS $1.6B, Roto-Rooter $900M.
From Chemed's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.